Deep learning algorithms can be used to forecast the number of COVID-19 cases and death cases. The multivariate CNN algorithm outperformed the LSTM in terms of validation accuracy and forecasting consistency. CNN has been suggested for long-term forecasting in the absence of seasonality and periodic patterns in time series datasets
[90][73]. The
presea
perrch mentioned that DL techniques have a significant impact on early detection of COVID-19 with high accuracy rate. Most of the studies used deep learning to detect COVID-19 cases in early stage based on different diagnostic techniques. The most widely used techniques are convolutional neural network (CNN) and transfer learning (TL)
[93][76]. The
presea
perrch detailed that the use of AI in COVID-19 investigation can be summarized in terms of clinical image examination, drug design and pandemic prediction against coronavirus. The study revealed that in a considerable number of patients with suspected COVID-19 pneumonia, CT should be examined following CXR, potentially causing impairment in the absence of pre-defined diagnostic work-up criteria. The DNN architectures are built from the ground up instead of applying transfer learning techniques
[94][77]. Deep Learning applications to detect the symptoms of COVID-19, AI based robots to maintain social distancing, Block chain technology to maintain patient records, Mathematical modeling to predict and assess the situation and Big Data to trace the spread of the virus and other technologies. These technologies have immensely contributed to curtailing this pandemic
[95][78]. In this
resear
ticlech, they designed a weakly supervised deep learning architecture for fast and fully-automated detection and classification of COVID-19 cases using retrospectively extracted CT images from multiple scanners and multiple centers. It can distinguish COVID-19 cases accurately from CAP (Community Acquired Pneumonia) and NP(Non-Pneumonia) patients. It can also spot the exact position of the lesions or inflammations caused by the COVID-19, and can also provide details about the patient severity in order to guide the following triage and treatment. Experimental findings have indicated that the proposed model achieves high accuracy, precision and promising qualitative visualisation for the lesion detections
[96][79]. This
resear
ticlech provide a solution for recognizing pneumonia due to COVID-19 and healthy lungs (normal person) using CXR (chest X-ray) images. They used the state-of-the-art technique, genetic deep learning convolutional neural network (GDCNN). It is trained from the scratch for extracting features for grouping them into COVID-19 and normal images. The proposed method do better compared to other transfer learning techniques. Classification accuracy of 98.84%, the precision of 93%, the sensitivity of 100%, and specificity of 97.0% in COVID-19 prediction is attained
[97][80]. As long as the number of patients is very high and the level of radiological expertise required is low, deep learning-based recommender systems can be of great assistance in diagnosing COVID-19. The study examined four different deep CNN architectures on chest X-ray images of COVID-19 patients for diagnosis recommendation. From all of the models, the Mobilenet model comes out on top. Based on the results, CNN-based architectures have the potential to diagnose COVID-19 correctly. Transfer learning plays a key role in improving detection accuracy. Further fine-tuning of these models may improve their accuracy
[98][81]. In this
presea
perrch they presented a clinical decision support system for the early detection of COVID-19 using deep learning based on chest X-ray images. For this, they developed an architecture made up of three stages. The first stage includes pre-processing of input images followed by data augmentation. The second stage includes feature extraction followed by learning. Finally, the third stage produces the classification and prediction process with a fully connected network of several classifiers. The proposed deep learning algorithm provided an AUC of 0.97 for internal validation and 0.95 for external validation based on the number of chest Xray images with an accuracy of 92.5% and 87.5% respectively
[99][82]. This
presea
perrch addresses how AI provides safe, accurate and efficient imaging solutions in COVID-19 applications. Two imaging techniques, i.e., X-ray and CT, are used to show the effectiveness of AI-empowered medical imaging for COVID-19. Imaging only gives partial information about patients with COVID-19. So, it is important to integrate imaging data with both clinical manifestations and laboratory examination results to help better screening, detection and diagnosis of COVID-19. AI will demonstrate its natural capability in fusing information from these multi-source data, for performing accurate and efficient diagnosis, analysis and follow-up
[96][79]. In this paper, the significance of the AI-driven tools and suitable training and testing models have been discussed. AI-driven tools are required to be implemented from the beginning of data collection, in parallel with the experts in the field, where active learning needs to be implemented. During the decision-making process, multiple data types should be used rather than just one in order to increase confidence. As part of active learning, multitudinal and multimodal data have been discussed
[100][83]. They presented an artificial intelligence (AI) system for rapid COVID-19 detection and extensively analyzed the CTs of COVID-19 based on Artificial Intelligence. They evaluated the system using large datasets consisting of more than 10 thousand CT scans from the COVID-19, influenza-A/B, community acquired pneumonia (CAP), and other subjects. On a test cohort of 3199 scans, the deep convolutional neural network-based system achieved an area under the receiver operating characteristic curve of 97.81%. This AI system outperformed all five radiologists in a reader study by two orders of magnitude when facing more challenging tasks
[101][84]. COVID-19 is a new disease announced on 11 February 2020. The major symptoms of COVID-19 are fever, breathing difficulty, dry cough, headache, runny nose, nasal blockage, body pain, and throat pain
[102][85]. The disease can easily transfer to others through droplets. Respiratory droplets >5–10 µm can spread the virus and are spread easily through direct contact compared to droplet nuclei with particle sizes <5 µm. The transmission of the droplet occurs within 1 m direct contact with a COVID-19-infected person. As of 22 May 202, there were 4,995,996 confirmed cases of coronavirus in over 216 countries and 3,27,821 confirmed deaths
[102][85]. The COVID-19 pandemic has exposed the vulnerability of healthcare services worldwide. There is a clear need to develop computer assisted diagnosis tools to provide rapid and cost-effective screening to identify SARS-CoV-2. CBC, chest X-ray, Polymerase Chain Reaction (PCR), chest CT, and the IgM/IgG combo test are the diagnosis methods that are generally utilized for COVID-19. Among these, CT scans produce the best performance in COVID-19 diagnosis
[103][86]. The artificial intelligence (AI) applications related to COVID-19 are involved in medical imaging, drug development, lung damage delineation, cough sample analysis, etc.
AI algorithms can take CT images of patients with clinical symptoms to diagnose COVID-19 result rapidly. A CNN is used to classify the medical image and diagnose the disease as pneumonia or COVID19. A linear support vector machine, VGG16, and Inception V3 were used in one study
[104][87]. Supervised machine learning algorithms such as SVM, random forest, and I Bayes are mostly utilized to predict the disease easily. The random forest provided the highest accuracy in 9 of 17 studies, with 53% overall. Among these studies, three SVMs produced the best classification for prediction of disease
[105][88]. Automatic investigative systems based on AI and ML devices have been developed to detect the coronavirus accurately and rapidly to protect healthcare workers in direct contact with COVID-19 patients
[106][89]. DeTraC DCNN is utilized to classify chest X-ray images (suspected COVID-19) accurately. It achieved 95.12% accuracy in the finding of coronavirus X-ray images
[104][87]. Extracting CT image features using a deep learning model could provide clinical diagnosis to save time
[107][90]. One of the challenging issues is distinguishing COVID-19 coughing sounds from non-COVID-19 coughing sounds. The AI4COVID19 application is used to record cough sound samples for 2 s. Matching the voice samples with coronavirus patients and non-COVID-19 patients was done with 90% accuracy
[108][91]. Deep learning techniques are utilized for computed tomography (CT) images to distinguish between coronavirus and pneumonia
[109][92]. COVID-19 and pneumonia X-ray image data classes were created using a fuzzy coloring technique for a preprocessing step. The preprocessing datasets were trained with DL models such as SqueezeNet and MobileNetV2. With up to 99.27% accuracy, a support vector machine is used to extract and classify the data features of COVID-19
[110][93].
Ten convolution neural network techniques were utilized to distinguish between coronavirus and non-coronavirus groups. Among all these networks, Xception and ResNet-101 both achieved high performance area under the curve (AUC) of 0.994. The radiologist’s performance was moderate with an AUC of 0.873
[111][94].
RestNet-100, a classifier made of a convolutional neural network (RCNN), combined with logistic regression (LR), was used to identify COVID-19. The CT scan image input is given to the Restnet101 deep convolutional neural network model that has 101 layers deep with 33 residual blocks. Then the result is passed to a logistic regression classifier. The logistic regression classifier classifies the result as COVID-19, normal, or pneumonia. The test produces 99.15% accuracy with COVID-19-positive patients. The COVID19 diagnosis has threshold values of 0 and 1. 1 indicates the person is affected with coronavirus or pneumonia, and the result zero indicates the person is not affected with coronavirus. To identify the patient’s condition from the initial stage to a severe stage, the threshold value is utilized for CT image classification. Threshold value 0.5 indicates the initial stage, and 1 indicates a severe condition
[103][86]. One of the latest techniques for COVID-19 diagnosis and classification is the depthwise separable convolution neural network (DWS-CNN) with a deep support vector machine (DSVM) enabled by the Internet of Things (IoT). The procedure consists of two stages, training and testing. It starts with collecting data from patients using IoT devises, and sending them to the cloud server via 5G networks. The aim of DWS-CNN is to determine the binary and multiple class labels of COVID-19 using CXR images. CNN is involved as the basis of new models used for predicting diseases, due to its efficiency at detecting structural abnormalities. This model was developed to improve the accuracy of COVID-19 detection from chest X-ray scans, and it minimizes manual interaction dependent on radiologists
[112][95].
Parkinson’s disease (PD) is an illness which could be diagnosed and detected by a CNN from drawing movements, using the Digitized Graphics Tablet dataset. This CNN includes two parts: feature extraction (convolutional layers) and classification (fully connected layers). The fast Fourier’s transform has the range of frequencies between 0 and 25 Hz, which are used as inputs to the CNN
[113,114,115][96][97][98]. Skin cancer is one of the most widespread causes of death, and early detection could increase the survival rate to 90%. For that purpose, deep convolutional neural networks (DCNNs) have been developed and applied to classify the color images of skin cancer into three types: melanoma, atypical nevus, and common nevus
[116,117,118][99][100][101].